The Need for Regulation to Positively Impact Drug Formulary Decisions to Ensure Appropriate Patient Access: A Little-Discussed Topic in Pharmaceutical Policy and Pricing Debate
As health care moves toward a value-based payment model, the pharmacy benefit is going in the opposite direction, one that places unit cost over clinical appropriateness.
Letter From the Editorial Board: Jan E. Berger, MD, MJ
Food as Medicine: Impact on Diabetes Management
This article addresses what employers need to know about food as medicine and offers practical steps to reduce barriers for their employee populations.
From the Editorial Board: Jan E. Berger, MD, MJ
Comparative Effectiveness Research and Formulary Placement: The Case of Diabetes
Formularies of the future should use evidence-produced CER to better target, not limit, diabetes care.
Prescriber Compliance With Black Box Warnings in Older Adult Patients
Elderly patients prescribed drugs with a drug-laboratory black box warning (BBW) had lower rates of prescriber BBW compliance than patients prescribed drugs with a drug-disease warning.
